Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Inventory (2025)

CG Oncology's Inventory history spans 1 years, with the latest figure at $1.6 million for Q4 2025.

  • For Q4 2025, Inventory changed N/A year-over-year to $1.6 million; the TTM value through Dec 2025 reached $1.6 million, changed N/A, while the annual FY2025 figure was $1.6 million, N/A changed from the prior year.
  • Inventory reached $1.6 million in Q4 2025 per CGON's latest filing, up from $1.5 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $1.6 million in Q4 2025 to a low of $1.5 million in Q3 2025.